New pancreatic cancer drug called a ‘miracle.’ What is daraxonrasib?

In clinical trials, the drug was shown to almost double the survival time for pancreatic cancer patients. Here’s how it works and who can get it.

Read more: https://www.usatoday.com/story/news/health/2026/05/14/pancreatic-cancer-drug-early-fda-access/90082539007/?utm_campaign=trueanthem&utm_medium=social&utm_source=youtube

Sign up for our newsletter for the day’s top stories, from sports to movies to politics to world events: https://profile.usatoday.com/newsletters/daily-briefing/